Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 22
10/31/2016 12:19:38 PM
10/31/2016 12:18:18 PM
10/28/2016 12:52:29 PM
10/28/2016 12:51:56 PM
10/28/2016 12:51:32 PM
10/28/2016 12:36:12 PM
10/28/2016 12:35:32 PM
10/28/2016 12:34:20 PM
10/28/2016 11:54:45 AM
10/28/2016 11:53:45 AM
10/28/2016 11:53:10 AM
10/28/2016 11:25:51 AM
10/28/2016 11:25:00 AM
10/28/2016 11:24:20 AM
10/27/2016 1:24:22 PM
10/27/2016 1:23:55 PM
10/27/2016 1:23:28 PM
10/27/2016 1:21:06 PM
10/27/2016 1:18:57 PM
10/27/2016 1:18:14 PM
10/27/2016 11:51:52 AM
10/27/2016 11:51:03 AM
10/27/2016 11:49:25 AM
10/27/2016 11:06:02 AM
10/27/2016 11:04:54 AM
10/27/2016 10:59:38 AM
10/26/2016 1:55:16 PM
10/26/2016 1:54:51 PM
10/26/2016 1:54:23 PM
10/26/2016 1:53:56 PM
10/26/2016 1:52:38 PM
10/26/2016 1:51:43 PM
10/26/2016 12:44:10 PM
10/26/2016 12:43:22 PM
10/26/2016 12:42:43 PM
10/26/2016 12:09:28 PM
10/26/2016 12:08:39 PM
10/26/2016 12:07:51 PM
10/25/2016 3:10:49 PM
10/25/2016 2:37:00 PM
10/25/2016 2:35:03 PM
10/25/2016 2:34:18 PM
10/25/2016 2:25:29 PM
10/25/2016 2:24:59 PM
10/25/2016 2:24:34 PM
10/25/2016 2:22:27 PM
10/25/2016 1:40:45 PM
10/25/2016 12:57:15 PM
10/25/2016 12:27:46 PM
10/25/2016 12:26:49 PM
Recent Articles
- Nextensa and Promobe Secure Long-Term Lease for New Offices
- China's Rare Earth Controls: An Uncertain Gamble Ahead
- Transform Your Finances: The Military Money Manual Unveiled
- FORVIA Reports Steady Q3 2025 Sales of €6.1 Billion
- High-Dose Influenza Vaccine Promises Greater Protection for Seniors
- Corbion Share Buyback Program Update: Significant Progress Made
- Roche's Gazyva/Gazyvaro Receives FDA Approval for Lupus Nephritis
- Vow ASA Reports Mixed Q3 Performance Amid Strong Market Demand
- TGS Secures Major OBN Acquisition Contract for Gulf of America
- Advancements in Bladder Cancer Treatment: Roche's Tecentriq Impact
- Sanofi's High-Dose Flu Vaccine Outperforms Standard Dosage
- ARTIS Zoo's New Certification: A Win for Urban Wildlife
- Zeekr Group to Release Q3 Financial Results; What's Next?
- Comfone Unveils Global 5G Standalone Roaming Services
- ARTIS Zoo Becomes Europe's First Certified Night Sky Place
- Tim Cook Applauds China's Remarkable Contribution to Apple
- Highlights from the 2025 World Internet Conference Preview
- Exploring the Essence of China-South Korea Relations Through Art
- Marko Law Firm Expands Footprint to Better Serve Michigan Residents
- Quantitative Brokers Unveils Advanced Trading Solutions in Brazil
- HTX's Airdrop Initiative: Supporting Traders Amid Market Chaos
- Insights on the AI Boom: Evaluating Valuations and Investment Opportunities
- Kyndryl's Latest AI Readiness Insights Sparks Transformation
- Tesla's Upcoming Earnings: Focus on Robotaxis and AI Integration
- Trump's Warning: Supreme Court Ruling May Harm U.S. Economy
- BC.GAME Esports Welcomes CS Major Champion electronic to Squad
- Elon Musk Defends Tesla's CEO Compensation Amid Criticism
- Chery Group Strengthens Commitment to Global Education Initiatives
- Revolutionizing Workplace Comfort with Elevated Seating Innovation
- Established Tech Giants Poised to Lead in AI Development
- ENGWE's Innovative Journey: Connecting E-Bike Riders Worldwide
- Investigation Ongoing After Daring Jewelry Heist at Louvre
- Unveiling Sustainable Solutions: Insights from Global Leaders
- SKYWORTH Launches Revolutionary Matte Screen Ultra TV Series
- Exciting Advances in Lung Cancer Treatment with Sacituzumab Tirumotecan
- MoonLake Immunotherapeutics: A Call to Action for Investors
- Investors Urged to Act Quickly in PubMatic Class Action Suit
- Tragic Cargo Plane Incident at Hong Kong Airport Sparks Concerns
- Christine Lagarde's Insight: Upcoming Tariff Effects on U.S. Consumers
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
